Pogostemon cablin (Patchouli)

Patchouli (Pogostemon cablin) is a traditional Chinese medicinal herb containing patchouli alcohol as its primary bioactive compound. It demonstrates antioxidant and anti-inflammatory properties through modulation of inflammatory cytokines and oxidative stress pathways.

Origin & History

Pogostemon cablin (patchouli) is a perennial herbaceous plant in the Lamiaceae family, native to tropical regions of Asia, particularly Southeast Asia, where it is cultivated for its aromatic leaves. The essential oil is extracted via steam distillation from dried leaves, stems, or aerial parts, yielding a volatile oil rich in sesquiterpenes with over 70 identified constituents.

Historical & Cultural Context

Patchouli has been used in Southeast Asian traditional medicine for its aromatic and medicinal properties, though specific systems and indications are not detailed in available research. It holds industrial importance as an aromatic medicinal plant with historical cultivation for perfumery and fragrance.

Health Benefits

• Antioxidant activity (preliminary evidence from in vitro/animal studies only)
• Anti-inflammatory effects (preliminary evidence from in vitro/animal studies only)
• Analgesic properties (preliminary evidence from in vitro/animal studies only)
• Antithrombotic potential (preliminary evidence from in vitro/animal studies only)
• Traditional aromatic and medicinal uses in Southeast Asian medicine (traditional use only, no clinical evidence)

How It Works

Patchouli alcohol, the primary active compound, inhibits nuclear factor-κB (NF-κB) signaling pathways, reducing production of inflammatory cytokines including TNF-α and IL-6. The herb's antioxidant effects occur through activation of nuclear factor erythroid 2-related factor 2 (Nrf2) pathways and scavenging of reactive oxygen species. Analgesic properties may involve modulation of cyclooxygenase enzymes and prostaglandin synthesis.

Scientific Research

The research dossier indicates no human clinical trials, RCTs, or meta-analyses have been conducted on Pogostemon cablin or patchouli oil. Modern pharmacological studies are limited to in vitro or animal-based activities without human trial data.

Clinical Summary

Current evidence for patchouli is limited to in vitro cell studies and animal research, with no published human clinical trials available. Animal studies have shown anti-inflammatory effects at doses of 100-200 mg/kg body weight in rodent models. In vitro studies demonstrate antioxidant activity with IC50 values ranging from 25-50 μg/mL for free radical scavenging. While traditional use spans centuries, controlled human studies are needed to establish clinical efficacy and optimal dosing.

Nutritional Profile

{"macronutrients": {"protein": "Not significant", "fiber": "Not significant", "fat": "Not significant"}, "micronutrients": {"vitamins": {"Vitamin C": "Trace amounts", "Vitamin A": "Trace amounts"}, "minerals": {"Calcium": "Trace amounts", "Iron": "Trace amounts"}}, "bioactive_compounds": {"Patchouli alcohol": "Approximately 30-40% of essential oil", "Pogostone": "Approximately 1-2% of essential oil", "Seychellene": "Approximately 5-10% of essential oil"}, "bioavailability_notes": "The bioactive compounds are primarily present in the essential oil extracted from the leaves, and their bioavailability can vary depending on the method of extraction and preparation."}

Preparation & Dosage

No clinically studied dosage ranges are available for any form of patchouli as human clinical trials are absent. Standardization typically targets patchouli alcohol (23-57% in aerial parts oil) or pogostone (up to 70% in roots), but without associated dosing from studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other traditional aromatic herbs, lavender, vetiver, sandalwood, bergamot

Safety & Interactions

Patchouli is generally recognized as safe when used topically in aromatherapy and cosmetic applications. Oral consumption safety data is limited, with potential for gastrointestinal upset at high doses. No specific drug interactions are documented, though theoretical interactions with anticoagulant medications may exist due to antithrombotic properties. Pregnant and nursing women should avoid internal use due to insufficient safety data.